Article · 29 Aug 2026
Conference abstract
DNA vaccine study against botulinum neurotoxin serotype E
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Botulinum neurotoxins (BoNTs) produced by Clostridium botulinum are the most toxic substance known and act by preventing the release of the neurotransmitter acetylcholine at the neuromuscular junction. Because of their high lethality, BoNTs are classified as category A agents by the Centers for Disease Control (CDC). Currently, there are no vaccines available to protect against BoNTs, so the rapid development of a safe and effective vaccine against BoNTs is important. DNA-based vaccines have recently drawn great attention because they can be developed quickly and can be applied in mass vaccination strategies to prevent outbreaks of disease. We studied the immunogenic and protective efficacy of a DNA vaccine delivered via the intradermal route, encoding a carboxyl-terminal fragment of the BoNT serotype E heavy chain. We synthesized gene fragment encoding non-toxic BoNTs heavy chain receptor (HCR) fragment as antigens using most frequently occurring codon in humans to code for each amino acid and inserted the synthetic genes in DNA vaccine plasmids (IgM-HCR). The antibodies against HCR were produced in Balb/c mice vaccinated with IgM-HCR via intradermal routes using in vivo electroporation. This IgM-HCR induced robust cellular and humoral BoNT/E-specific immune responses and completely protected mice against lethal challenge with BoNT/E toxin. These results indicated that DNA vaccines could be further developed as safe and effective candidates for vaccines against BoNT-E.
Keywords
Subjects
Vaccines & ImmunisationAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Vaccines & Vaccination.
Article · 29 Aug 2026
Advances in Adjuvant Development for Enhanced Vaccine Performance and Long-Term Immune Protection
Article · 20 Jun 2026
Herd Immunity and Its Role in Controlling Infectious Diseases
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Vaccines & Vaccination
- SubjectVaccines & Immunisation
- BylineArticles whose byline prints “Won Rak Son”
- BylineArticles whose byline prints “Na Young Kim”
- BylineArticles whose byline prints “Jun Young Choi”
- BylineArticles whose byline prints “Chi Ho Yu”
- BylineArticles whose byline prints “Gyeung Haeng Hur”
- BylineArticles whose byline prints “Sungho Shin”
- BylineArticles whose byline prints “Young Kee Shin”
